Few Mutual Funds Are Fans
Of Biotech Stocks Despite Rally

If you are thinking about buying into the scorching rally in many biotechnology stocks, don't count on your mutual fund to help you.

Over the past few days, the share prices of many biotechnology stocks have skyrocketed, in part triggered by the news that EntreMed Inc., a small, Rockville, Md., company, had developed two drugs that have killed cancer tumors in mice. On Monday, EntreMed's shares quadrupled on the Nasdaq Stock Market....